戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 626作成日:2026年10月24日

2-Bromo-3-chloropyridine → 5-[(3-Chloro-2-pyridinyl)amino]-1-methylpiperidin-2-one

https://huagongshe.com/ja/reaction/626

反応式

関与物質

役割名称HCID仕込み量
反応物2-Bromo-3-chloropyridineHCID 7016326—
反応物5-Amino-1-methylpiperidin-2-oneHCID 51072176—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物5-[(3-Chloro-2-pyridinyl)amino]-1-methylpiperidin-2-oneHCID 646695950%

反応条件

温度115 °C

反応手順

In a 10 ml MW vial, Pd2((dba)3 (10.85 mg, 0.01 mmol), 2,2'-bis(diphenylphosphanyl)-1,1'-binaphthalene (BINAP) (14.56 mg, 0.02 mmol), sodium 2-methylpropan-2-olate (261 mg, 2.71 mmol), 5-amino-1-methylpiperidin-2-one (200 mg, 1.56 mmol) and 2-bromo-3-chloropyridine (300 mg, 1.56 mmol) mixed in toluene (3 mL) to give a brown suspension. The mixture was degassed with N2 bubbling for 5 min, then the vial was capped and the reaction stirred at 115°C in an oil-bath for 1h then to rt for 2h. LC-MS 1h: 15% product. LC-MS o/n: 19% product. The reaction was cooled to rt and the solvent was evaporated. The residue was purified by automated flash chromatography on a 50g column. A gradient from 20% to 100% of EtOAc in heptane over 20CV was used as mobile phase. The product was collected using the wavelength 307 and 241 nm. Product was not found in any of the fractions, reaction discarded.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-66ec8d5c98634ce5baad8122520ec3b5
出典メモ750 AstraZeneca ELN dataset